MERSANA THERAPEUTICS INC (MRSN)
US59045L1061 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 78.87M | 174.56M | 128.90M | 177.90M | 255.10M | |||
| Marketable Securities | 76.30M | 34.52M | 151.80M | N/A | 0.00 | |||
| Receivables | 1.00M | 0.00 | 30.00M | N/A | N/A | |||
| Other Current Assets | 4.39M | 4.97M | 8.50M | 11.00M | 3.50M | |||
| Total Current Assets | 160.56M | 214.06M | 319.20M | 188.90M | 258.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.00M | 11.53M | 14.50M | 14.90M | 12.70M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 978.00K | 478.00K | 700.00K | 2.40M | 2.20M | |||
| Total Non-Current Assets | 8.97M | 12.00M | 15.10M | 17.20M | 14.80M | |||
| TOTAL ASSETS | 169.53M | 226.06M | 334.30M | 206.10M | 273.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 11.46M | 2.23M | 200.00K | 200.00K | 100.00K | |||
| Accrued Expenses | 22.38M | 25.15M | 46.00M | 31.00M | 17.60M | |||
| Accounts Payable | 2.03M | 7.32M | 14.00M | 12.30M | 8.30M | |||
| Other Current Liabilities | 32.43M | 28.94M | 31.40M | 3.90M | 4.00M | |||
| Total Current Liabilities | 68.30M | 63.64M | 91.50M | 47.50M | 30.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 14.00M | 23.20M | 25.10M | 25.10M | 5.20M | |||
| Other Non-Current Liabilities | 86.18M | 102.32M | 125.60M | 11.80M | 10.20M | |||
| Total Non-Current Liabilities | 100.18M | 125.52M | 150.80M | 36.90M | 15.30M | |||
| TOTAL LIABILITIES | 168.48M | 189.16M | 242.30M | 84.40M | 45.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -881.44M | -826.36M | -654.70M | -450.50M | -280.40M | |||
| Additional Paid In Capital | 882.45M | 863.24M | 746.90M | 572.20M | 508.50M | |||
| Common Shares | 12.00K | 12.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 25.00K | 11.00K | -200.00K | N/A | 0.00 | |||
| Shares Outstanding | 122.87M | 120.71M | 105.10M | 73.70M | 68.80M | |||
| Tangible Book Value per Share | 0.01 | 0.31 | 0.88 | 1.65 | 3.32 | |||
| Total Shareholders' Equity | 1.05M | 36.90M | 92.10M | 121.70M | 228.10M | |||
| TOTAL LIABILITIES AND EQUITY | 169.53M | 226.06M | 334.30M | 206.10M | 273.40M | |||
| Statistics | ||||||||
| Debt/Equity | 13.35 | 0.63 | 0.27 | 0.21 | 0.02 | |||
| Current Ratio | 2.35 | 3.36 | 3.49 | 3.98 | 8.62 | |||
| Return On Assets (ROA) | -44.02% | -75.94% | -61.09% | -82.51% | -32.21% | |||
| Return On Equity (ROE) | -7113.35% | -465.18% | -221.73% | -139.74% | -38.60% | |||
All data in USD , ROIC based on taxRate of 0.21